Table 3.
PI-RADSv2.1 and PI-RADSv2 scores assigned by the three groups of readers
Benign lesions & ISUP 1 cancers | csPCas | |||||||
---|---|---|---|---|---|---|---|---|
Experienced seniors | Less experienced seniors | Juniors | Experienced seniors | Less experienced seniors | Juniors | |||
Predefined lesions (N = 240) | PI-RADSv2.1 | 1 | 4 [2–12] | 4 [1–5] | 8 [2–9] | 1 [0–2] | 1 [0–1] | 1 [0–1] |
2 | 49 [20–61] | 20 [14–39] | 22 [19–52] | 5 [3–6] | 0 [0–2] | 4 [2–9] | ||
3 | 24 [18–29] | 15 [12–18] | 33 [28–34] | 5 [4–7] | 4 [3–6] | 8 [3–11] | ||
4 | 65 [44–86] | 96 [90–111] | 73 [56–95] | 35 [34–39] | 39 [38–41] | 35 [34–39] | ||
5 | 11 [8–15] | 13 [11–20] | 15 [10–24] | 32 [28–36] | 33 [30–35] | 32 [26–35] | ||
PI-RADSv2.0 | 1 | 3 [1–10] | 2 [1–3] | 2 [1–7] | 1 [0–3] | 0 [0–0] | 0 [0–1] | |
2 | 28 [17–41] | 23 [12–24] | 21 [12–23] | 3 [2–5] | 1 [0–4] | 2 [1–3] | ||
3 | 26 [21–32] | 16 [12–18] | 38 [29–44] | 5 [5–7] | 3 [2–4] | 10 [3–12] | ||
4 | 87 [49–97] | 105 [100–112] | 78 [71–97] | 38 [34–40] | 40 [38–43] | 41 [37–42] | ||
5 | 11 [9–15] | 13 [11–19] | 15 [11–24] | 32 [28–36] | 34 [31–35] | 32 [26–35] | ||
Per-lobe analysis (N = 318) | PI-RADSv2.1 | 1 | 71 [7–78] | 49 [8–58] | 50 [22–57] | 4 [0–7] | 1 [0–3] | 4 [2–6] |
2 | 57 [48–60] | 49 [21–75] | 40 [37–61] | 5 [4, 5] | 3 [2–7] | 4 [2–5] | ||
3 | 33 [22–33] | 17 [14–18] | 37 [32–47] | 5 [3–6] | 5 [2–10] | 8 [3–10] | ||
4 | 60 [46–88] | 99 [89–108] | 77 [58–96] | 36 [32–39] | 37 [37–39] | 36 [35–38] | ||
5 | 18 [11–23] | 15 [12–23] | 19 [15–35] | 43 [36–49] | 42 [39–44] | 43 [35–49] | ||
PI-RADSv2.0 | 1 | 1 [0–2] | 1 [0–2] | 1 [0–3] | 0 [0–1] | 0 [0–0] | 0 [0–1] | |
2 | 107 [77–114] | 82 [63–89] | 65 [58–83] | 6 [5–11] | 7 [5–9] | 6 [4–8] | ||
3 | 31 [22–39] | 15 [11–23] | 37 [28–51] | 5 [3–6] | 3 [2–4] | 8 [3–10] | ||
4 | 79 [54–101] | 106 [102–112] | 81 [72–98] | 39 [31–41] | 38 [36–41] | 38 [36–40] | ||
5 | 18 [11–24] | 15 [12–22] | 19 [15–35] | 43 [36–49] | 42 [42–46] | 43 [36–49] |
Data are presented as median number of lesions/lobes [interquartile range]
N Number of lesions/lobes, csPCas Clinically significant prostate cancers, ISUP International society of urological pathology, PI-RADS prostate imaging-reporting and data system